• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

混合性神经纤维瘤-施万细胞瘤

Hybrid Neurofibroma-Schwannoma.

作者信息

Hussain Namath S, Specht Charles S, Frauenhoffer Elizabeth, Glantz Michael, Harbaugh Kimberly

机构信息

Department of Neurosurgery, Penn State Hershey Medical Center.

Pathology, Penn State Hershey Medical Center.

出版信息

Cureus. 2016 Mar 30;8(3):e548. doi: 10.7759/cureus.548.

DOI:10.7759/cureus.548
PMID:27158577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4852185/
Abstract

Neurofibromas and schwannomas are common lesions that may be idiopathic or may occur in association with neural crest genetic syndromes such as neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. A hybrid tumor that contains pathological characteristics of both neurofibroma and schwannoma has been described as a rare entity. We present the clinical, radiographic, and pathological findings of such a case.

摘要

神经纤维瘤和神经鞘瘤是常见的病变,可能是特发性的,也可能与神经嵴遗传综合征相关,如1型神经纤维瘤病、2型神经纤维瘤病和神经鞘瘤病。一种兼具神经纤维瘤和神经鞘瘤病理特征的混合性肿瘤已被描述为一种罕见的实体。我们展示了这样一个病例的临床、影像学和病理结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/17f39ed680bb/cureus-0008-000000000548-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/ca91f499482c/cureus-0008-000000000548-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/41114ffef437/cureus-0008-000000000548-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/a184a00ec8cf/cureus-0008-000000000548-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/bb45002bf1c7/cureus-0008-000000000548-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/f28abfab77ed/cureus-0008-000000000548-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/160fc760ea9a/cureus-0008-000000000548-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/17f39ed680bb/cureus-0008-000000000548-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/ca91f499482c/cureus-0008-000000000548-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/41114ffef437/cureus-0008-000000000548-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/a184a00ec8cf/cureus-0008-000000000548-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/bb45002bf1c7/cureus-0008-000000000548-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/f28abfab77ed/cureus-0008-000000000548-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/160fc760ea9a/cureus-0008-000000000548-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a068/4852185/17f39ed680bb/cureus-0008-000000000548-i07.jpg

相似文献

1
Hybrid Neurofibroma-Schwannoma.混合性神经纤维瘤-施万细胞瘤
Cureus. 2016 Mar 30;8(3):e548. doi: 10.7759/cureus.548.
2
Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients.神经纤维瘤/雪旺细胞瘤混合瘤在神经鞘瘤病和神经纤维瘤病患者中较为多见。
Am J Surg Pathol. 2012 May;36(5):702-9. doi: 10.1097/PAS.0b013e31824d3155.
3
Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.神经纤维瘤/神经鞘瘤的分子分析鉴定出常见的单体型 22 和 α-T-连环蛋白/CTNNA3 是一种新的候选肿瘤抑制基因。
Am J Pathol. 2016 Dec;186(12):3285-3296. doi: 10.1016/j.ajpath.2016.08.019. Epub 2016 Oct 17.
4
Hybrid Schwannoma/Neurofibroma of the Neck: A Case Report.颈部混合型施万细胞瘤/神经纤维瘤:一例报告
Ear Nose Throat J. 2023 Sep 25:1455613231200834. doi: 10.1177/01455613231200834.
5
Hybrid peripheral nerve sheath tumor.混合性周围神经鞘瘤。
J Neurosurg. 2012 Nov;117(5):897-901. doi: 10.3171/2012.8.JNS111841. Epub 2012 Sep 14.
6
Intraneural Hybrid Neurofibroma/Schwannoma In Scalp: A Case Report.头皮内神经混合型神经纤维瘤/施万细胞瘤:一例报告
J Clin Diagn Res. 2015 Oct;9(10):ED05-6. doi: 10.7860/JCDR/2015/15723.6600. Epub 2015 Oct 1.
7
Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.65例施万细胞瘤病患者的脊髓神经鞘瘤与831例孤立性神经鞘瘤及102例2型神经纤维瘤病患者的临床特征比较:单机构回顾性研究
J Neurosurg Spine. 2016 Jan;24(1):145-54. doi: 10.3171/2015.3.SPINE141145. Epub 2015 Sep 25.
8
Oral plexiform schwannoma: A case report and relevant immunohistochemical investigation.口腔丛状神经鞘瘤:一例报告及相关免疫组织化学研究。
SAGE Open Med Case Rep. 2019 Mar 19;7:2050313X19838184. doi: 10.1177/2050313X19838184. eCollection 2019.
9
Tumors displaying hybrid schwannoma and neurofibroma features in patients with neurofibromatosis type 2.2型神经纤维瘤病患者中表现出混合性施万细胞瘤和神经纤维瘤特征的肿瘤。
Clin Neuropathol. 2016 Mar-Apr;35(2):78-83. doi: 10.5414/NP300895.
10
Neurofibroma and schwannoma.神经纤维瘤和神经鞘瘤。
Curr Opin Neurol. 2002 Dec;15(6):679-84. doi: 10.1097/01.wco.0000044763.39452.aa.

引用本文的文献

1
Hybrid nerve sheath tumor of the spinal canal and neurofibromatosis-2, where the twain shall meet-a case report and review of literature.椎管混合性神经鞘瘤与神经纤维瘤病2型——二者相遇之处:一例病例报告及文献复习
J Med Case Rep. 2025 Feb 27;19(1):78. doi: 10.1186/s13256-025-05083-8.
2
Intramuscular Hybrid Nerve Sheath Tumor of the Thigh: Case Report and Literature Review.大腿部肌间混合性神经鞘瘤:病例报告及文献复习。
In Vivo. 2024 Mar-Apr;38(2):971-974. doi: 10.21873/invivo.13529.
3
Primary extradural tumors of the spinal column: A comprehensive treatment guide for the spine surgeon based on the 5 Edition of the World Health Organization bone and soft-tissue tumor classification.

本文引用的文献

1
An unusual case of schwannomatosis with bilateral maxillary sinus schwannomas and a novel SMARCB1 gene mutation.一例罕见的双侧上颌窦神经鞘瘤型神经鞘瘤病及一种新的SMARCB1基因突变
J Neurosurg Spine. 2016 Jan;24(1):160-6. doi: 10.3171/2015.4.SPINE15192. Epub 2015 Oct 2.
2
A benign cutaneous plexiform hybrid tumor of perineurioma and cellular neurothekeoma.具有神经膜瘤和细胞性神经鞘瘤特征的良性皮肤丛状混合瘤。
Am J Surg Pathol. 2013 Jun;37(6):845-52. doi: 10.1097/PAS.0b013e31827edfda.
3
Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.
脊柱原发性硬膜外肿瘤:基于世界卫生组织骨与软组织肿瘤分类第5版的脊柱外科医生综合治疗指南
J Craniovertebr Junction Spine. 2021 Oct-Dec;12(4):336-360. doi: 10.4103/jcvjs.jcvjs_115_21. Epub 2021 Dec 11.
4
Schwannoma and Neurofibroma, Originating from the Ulnar Nerve in Neurofibromatosis: A Case Report and Review of the Literature.神经纤维瘤病中起源于尺神经的施万细胞瘤和神经纤维瘤:一例报告并文献复习
Surg J (N Y). 2020 Sep 10;6(3):e139-e144. doi: 10.1055/s-0040-1712536. eCollection 2020 Jul.
5
Supraclavicular Solitary Hybrid Schwannoma/Neurofibroma: A Case Report.锁骨上孤立性混合性施万瘤/神经纤维瘤:一例报告
Cureus. 2020 Jun 9;12(6):e8531. doi: 10.7759/cureus.8531.
2011 年国际许旺细胞瘤研讨会最新进展:从遗传学角度到诊断标准。
Am J Med Genet A. 2013 Mar;161A(3):405-16. doi: 10.1002/ajmg.a.35760. Epub 2013 Feb 7.
4
Malignant peripheral nerve sheath tumours in inherited disease.遗传性疾病中的恶性周围神经鞘膜瘤。
Clin Sarcoma Res. 2012 Oct 4;2(1):17. doi: 10.1186/2045-3329-2-17.
5
Hybrid peripheral nerve sheath tumor.混合性周围神经鞘瘤。
J Neurosurg. 2012 Nov;117(5):897-901. doi: 10.3171/2012.8.JNS111841. Epub 2012 Sep 14.
6
Clinical features of schwannomatosis: a retrospective analysis of 87 patients.神经鞘瘤病的临床特征:87 例回顾性分析。
Oncologist. 2012;17(10):1317-22. doi: 10.1634/theoncologist.2012-0162. Epub 2012 Aug 27.
7
Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients.神经纤维瘤/雪旺细胞瘤混合瘤在神经鞘瘤病和神经纤维瘤病患者中较为多见。
Am J Surg Pathol. 2012 May;36(5):702-9. doi: 10.1097/PAS.0b013e31824d3155.
8
Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems.周围神经鞘瘤的病理学:诊断概述及部分诊断问题的更新。
Acta Neuropathol. 2012 Mar;123(3):295-319. doi: 10.1007/s00401-012-0954-z. Epub 2012 Feb 12.
9
INI1-deficient tumors: diagnostic features and molecular genetics.INI1 缺陷型肿瘤:诊断特征和分子遗传学。
Am J Surg Pathol. 2011 Oct;35(10):e47-63. doi: 10.1097/PAS.0b013e31822b325b.
10
Hybrid peripheral nerve sheath tumor of the nasal cavity showing schwannomatous, neurofibromatous, and perineuriomatous areas.鼻腔混合性周围神经鞘瘤,可见施万细胞瘤、神经纤维瘤及神经束膜瘤区域。
Med Mol Morphol. 2010 Jun;43(2):82-5. doi: 10.1007/s00795-008-0418-7. Epub 2010 Aug 4.